Prior work has suggested that secondary bile acids are the primary ligand for TGR5 [56] through which they may suppress pro-inflammatory signaling [55, 57], resulting in impaired immunity to viral infections [58, 59]. The gene discussed is GPBAR1; the disease is viral infectious disease.